dimethoate has been researched along with Pancreatic Neoplasms in 1 studies
Dimethoate: An organothiophosphorus cholinesterase inhibitor that is used as a systemic and contact insecticide.
dimethoate : A monocarboxylic acid amide that is N-methylacetamide in which one of the hydrogens of the methyl group attached to the carbonyl moiety is replaced by a (dimethoxyphosphorothioyl)sulfanediyl group.
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H | 1 |
| Wu, B | 1 |
| Ge, Y | 1 |
| Huang, J | 1 |
| Song, S | 1 |
| Wang, C | 1 |
| Yao, J | 1 |
| Liu, K | 1 |
| Li, Y | 2 |
| Ma, X | 1 |
1 other study available for dimethoate and Pancreatic Neoplasms
| Article | Year |
|---|---|
Phosphamide-containing diphenylpyrimidine analogues (PA-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with enhanced activity against pancreatic cancer cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dimethoate; Dose-Response Relationship, | 2017 |